Anticancer potential of pomegranate

Pomegranates: Ancient Roots to Modern Medicine

Volumn , Issue , 2006, Pages 107-116

  Shishodia, Shishir ^a   Adams, Lynn ^b   Bhatt, Indra D ^c   Aggarwal, Bharat B ^c  

^a TEXAS SOUTHERN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84983397045     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (29)

1. Longtin, R., The pomegranate: nature’s power fruit? J. Natl. Cancer Inst., 95, 346, 2003.
2. Burton, A., Chemoprevention: eat ginger, rub on pomegranate, Lancet Oncol., 4, 715, 2003.
3. van Elswijk, D.A. et al., Rapid dereplication of estrogenic compounds in pomegranate (Punica granatum) using on-line biochemical detection coupled to mass spectrometry, Phytochemistry, 65, 233, 2004.
4. Noda, Y. et al., Antioxidant activities of pomegranate fruit extract and its anthocyanidins: delphinidin, cyanidin, and pelargonidin, J. Agric. Food Chem., 50, 166, 2002.
5. de Nigris, F. et al., Beneficial effects of pomegranate juice on oxidation-sensitive genes and endothelial nitric oxide synthase activity at sites of perturbed shear stress, Proc. Natl. Acad. Sci. USA, 102, 4896, 2005.
6. Mehta, R. and Lansky, E.P., Breast cancer chemopreventive properties of pomegranate (Punica granatum) fruit extracts in a mouse mammary organ culture, Eur. J. Cancer Prev., 13, 345, 2004.
7. Kim, N.D, et al., Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer, Breast Cancer Res. Treat., 71, 203, 2002.
8. Settheetham, W. and Ishida, T., Study of genotoxic effects of antidiarrheal medicinal herbs on human cells in vitro, Southeast Asian J. Trop. Med. Public Health, 26 Suppl 1, 306, 1995.
9. Lansky, E.P. et al., Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions, Invest. New Drugs, 23, 11, 2005.
10. Albrecht, M. et al., Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells, J. Med. Food., 7, 274, 2004.
11. Malik, A. et al., Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer, Proc. Natl. Acad. Sci. USA, 102, 14813, 2005.
12. Freeman, M.R. and Solomon, K.R., Cholesterol and prostate cancer, J. Cell Biochem., 91, 54, 2004.
13. Fuhrman, B., Volkova, N., and Aviram, M., Pomegranate juice inhibits oxidized LDL uptake and cholesterol biosynthesis in macrophages, J. Nutr. Biochem., 16, 570, 2005.
14. Seeram, N.P. et al., In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice, J. Nutr. Biochem., 16, 360, 2005.
15. Kohno, H. et al., Pomegranate seed oil rich in conjugated linolenic acid suppresses chemically induced colon carcinogenesis in rats, Cancer Sci., 95, 481, 2004.
16. Afaq, F. et al., Pomegranate fruit extract modulates UV-B-mediated phosphorylation of mitogen-activated protein kinases and activation of nuclear factor kappa B in normal human epidermal keratinocytes paragraph sign, Photochem. Photobiol., 81, 38, 2005.
17. Hora, J.J. et al., Chemopreventive effects of pomegranate seed oil on skin tumor development in CD1 mice, J. Med. Food, 6, 157, 2003.
18. Kawaii, S. and Lansky, E.P., Differentiation-promoting activity of pomegranate (Punica granatum) fruit extracts in HL-60 human promyelocytic leukemia cells, J. Med. Food, 7, 13, 2004.
19. Schubert, S.Y., Lansky, E.P., and Neeman, I., Antioxidant and eicosanoid enzyme inhibition properties of pomegranate seed oil and fermented juice flavonoids, J. Ethnopharmacol., 66, 11, 1999.
20. Afaq, F. et al., Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice, Int. J. Cancer, 113, 423, 2005.
21. Adams, L. et al., Pomegranate juice, total pomegranate ellagitanins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. J. Agric. Food Chem., 54, 980, 2006.
22. Loch, T. et al., Vascular endothelial growth factor (VEGF) and its role in neoplastic processes, Postepy Hig. Med. Dosw., 55, 257, 2001.
23. Chilov, D. et al., Genomic organization of human and mouse genes for vascular endothelial growth factor C, J. Biol. Chem., 272, 25176, 1997.
24. Toi, M. et al., Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo, Angiogenesis, 6, 121, 2003.
25. Farina, A.R. et al., Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor kappaB elements, Cell Growth Differ., 10, 353, 1999.
26. Bond, M. et al., Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NFkappa B, FEBS Lett., 435, 29, 1998.
27. Novak, U., Cocks, B.G., and Hamilton, J.A., A labile repressor acts through the NFkBlike binding sites of the human urokinase gene, Nucleic Acids Res., 19, 3389, 1991.
28. Ahmed, S. et al., Punica granatum L. extract inhibits IL-1(beta)-induced expression of matrix metalloproteinases by inhibiting the activation of MAP kinases and NF-(kappa)B in human chondrocytes in vitro, J. Nutr., 135, 2096, 2005.
29. Lansky, E.P, et al., Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel, Invest New Drugs, 23, 121, 2005.